News

The patent assigned to Odyssey Thera, further protects assays utilizing fragments of inherently fluorescent proteins, and the use of the assays for screening of defined panels of proteins.

ALD-401 is the population of stem cells produced using Aldagen’s proprietary technology to sort a specified quantity of bone marrow collected from the patient receiving the therapy. Preclinical

Omeros claims that its proprietary antifibrinolytic agents are highly selective inhibitors of plasmin, the enzyme responsible for fibrinolysis and dissolving blood clots, while avoiding inhibition of Factor XIa

Under the agreement, both the parties are expected to investigate RNA-based drug candidates using AVI’s proprietary, intrinsically charge-neutral, phosphorodiamidate morpholino oligomer (PMO) based chemistry platform. The intellectual property

As the chief scientific officer, Romanos has led the formation of the company and the development of its proprietary antibody fragment technologies. Crescendo chairman Clive Dix said that

Most recently, Greig has worked with GlaxoSmithKline’ (GSK) Corporate Venture Group, SR One. Greig has held senior leadership positions in GSK, Advanced Technologies, Rib-X Pharmaceuticals and Anaphore in

Aquinox Pharma’s Phase 1 AQX-1125 is a three part study in healthy volunteers. The primary objectives of Phase I are to evaluate the safety, tolerability and pharmacokinetics of

Under the agreement, Ranbaxy was expected to receive around $100m payment from the American drug company, Merck, Economic Times reported. Reportedly, Merck has transferred the research programs to

Rivaroxaban is an oral anticoagulant being evaluated for the prevention and treatment of a range of disorders in which blood clotting plays a major role. According to J&JPRD,